The Filings Report

Xylem Inc

XYLNYSECIK 1524472Industrials / Specialty Industrial Machineryfiscal year ends December65 quarters since 2010

Revenue, Q3 FY2026
$2.2B
−3.0% on Q3 FY2025
Net income
$291M
+28.2% on Q3 FY2025
Free cash flow
$242M
−13.9% on Q3 FY2025
Diluted EPS
$1.25
+34.4% on Q3 FY2025
Revenue, TTM
$9.1B
trailing four quarters
Net margin, TTM
11.9%
net income $1.1B
Free cash flow, TTM
$921M
$1.3B less $351M capex
Cash and equivalents
$708M
long-term debt $2.4B, Sep 30, 2026
Shares, 12-month change
−5.8%
229M shares, Sep 30, 2026
Buybacks, TTM
$1.6B
7.5% of market value
Dividends, TTM
$405M
1.9% of market value
Market value
$21.2B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 27, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Xylem Inc reported revenue of $2.2B, −3.0% on Q3 FY2025, and net income of $291M (+28.2%). Operating margin was 17.5%. Free cash flow, operating cash flow less capital expenditures, was $242M ($331M less $89M). Diluted earnings per share were $1.25.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 27, 2026.

Revenue and net incomeRevenueNet income
$0$1B$2B$3BQ4'22, Revenue: $1.5BQ4'22, Net income: $149MQ4'22Q1'23, Revenue: $1.4BQ1'23, Net income: $99MQ1'23Q2'23, Revenue: $1.7BQ2'23, Net income: $92MQ2'23Q3'23, Revenue: $2.1BQ3'23, Net income: $152MQ3'23Q4'23, Revenue: $2.1BQ4'23, Net income: $266MQ4'23Q1'24, Revenue: $2.0BQ1'24, Net income: $153MQ1'24Q2'24, Revenue: $2.2BQ2'24, Net income: $194MQ2'24Q3'24, Revenue: $2.1BQ3'24, Net income: $217MQ3'24Q4'24, Revenue: $2.3BQ4'24, Net income: $326MQ4'24Q1'25, Revenue: $2.1BQ1'25, Net income: $169MQ1'25Q2'25, Revenue: $2.3BQ2'25, Net income: $226MQ2'25Q3'25, Revenue: $2.3BQ3'25, Net income: $227MQ3'25Q4'25, Revenue: $2.4BQ4'25, Net income: $335MQ4'25Q1'26, Revenue: $2.1BQ1'26, Net income: $193MQ1'26Q2'26, Revenue: $2.3BQ2'26, Net income: $263MQ2'26Q3'26, Revenue: $2.2BQ3'26, Net income: $291MQ3'26$0$1B$2B$3BQ4'22, Revenue: $1.5BQ4'22, Net income: $149MQ1'23, Revenue: $1.4BQ1'23, Net income: $99MQ1'23Q2'23, Revenue: $1.7BQ2'23, Net income: $92MQ3'23, Revenue: $2.1BQ3'23, Net income: $152MQ3'23Q4'23, Revenue: $2.1BQ4'23, Net income: $266MQ1'24, Revenue: $2.0BQ1'24, Net income: $153MQ1'24Q2'24, Revenue: $2.2BQ2'24, Net income: $194MQ3'24, Revenue: $2.1BQ3'24, Net income: $217MQ3'24Q4'24, Revenue: $2.3BQ4'24, Net income: $326MQ1'25, Revenue: $2.1BQ1'25, Net income: $169MQ1'25Q2'25, Revenue: $2.3BQ2'25, Net income: $226MQ3'25, Revenue: $2.3BQ3'25, Net income: $227MQ3'25Q4'25, Revenue: $2.4BQ4'25, Net income: $335MQ1'26, Revenue: $2.1BQ1'26, Net income: $193MQ1'26Q2'26, Revenue: $2.3BQ2'26, Net income: $263MQ3'26, Revenue: $2.2BQ3'26, Net income: $291MQ3'26

Net income losses drawn in red.

Free cash flow
−$200M$0$200M$400M$600MQ4'22, Free cash flow: $302MQ4'22Q1'23, Free cash flow: −$68MQ1'23Q2'23, Free cash flow: −$25MQ2'23Q3'23, Free cash flow: $299MQ3'23Q4'23, Free cash flow: $361MQ4'23Q1'24, Free cash flow: $15MQ1'24Q2'24, Free cash flow: $215MQ2'24Q3'24, Free cash flow: $237MQ3'24Q4'24, Free cash flow: $475MQ4'24Q1'25, Free cash flow: −$38MQ1'25Q2'25, Free cash flow: $207MQ2'25Q3'25, Free cash flow: $281MQ3'25Q4'25, Free cash flow: $460MQ4'25Q1'26, Free cash flow: $18MQ1'26Q2'26, Free cash flow: $201MQ2'26Q3'26, Free cash flow: $242MQ3'26−$200M$0$200M$400M$600MQ4'22, Free cash flow: $302MQ1'23, Free cash flow: −$68MQ1'23Q2'23, Free cash flow: −$25MQ3'23, Free cash flow: $299MQ3'23Q4'23, Free cash flow: $361MQ1'24, Free cash flow: $15MQ1'24Q2'24, Free cash flow: $215MQ3'24, Free cash flow: $237MQ3'24Q4'24, Free cash flow: $475MQ1'25, Free cash flow: −$38MQ1'25Q2'25, Free cash flow: $207MQ3'25, Free cash flow: $281MQ3'25Q4'25, Free cash flow: $460MQ1'26, Free cash flow: $18MQ1'26Q2'26, Free cash flow: $201MQ3'26, Free cash flow: $242MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$1B$2B$3BQ4'22, Cash and equivalents: $944MQ4'22, Long-term debt: $1.9BQ4'22Q1'23, Cash and equivalents: $837MQ1'23, Long-term debt: $1.9BQ1'23Q2'23, Cash and equivalents: $708MQ2'23, Long-term debt: $2.3BQ2'23Q3'23, Cash and equivalents: $705MQ3'23, Long-term debt: $2.3BQ3'23Q4'23, Cash and equivalents: $1.0BQ4'23, Long-term debt: $2.3BQ4'23Q1'24, Cash and equivalents: $947MQ1'24, Long-term debt: $2.0BQ1'24Q2'24, Cash and equivalents: $815MQ2'24, Long-term debt: $2.0BQ2'24Q3'24, Cash and equivalents: $989MQ3'24, Long-term debt: $2.0BQ3'24Q4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $2.0BQ4'24Q1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $2.0BQ1'25Q2'25, Cash and equivalents: $1.2BQ2'25, Long-term debt: $1.9BQ2'25Q3'25, Cash and equivalents: $1.2BQ3'25, Long-term debt: $1.9BQ3'25Q4'25, Cash and equivalents: $1.5BQ4'25, Long-term debt: $1.4BQ4'25Q1'26, Cash and equivalents: $808MQ1'26, Long-term debt: $1.4BQ1'26Q2'26, Cash and equivalents: $1.3BQ2'26, Long-term debt: $2.4BQ2'26Q3'26, Cash and equivalents: $708MQ3'26, Long-term debt: $2.4BQ3'26$0$1B$2B$3BQ4'22, Cash and equivalents: $944MQ4'22, Long-term debt: $1.9BQ1'23, Cash and equivalents: $837MQ1'23, Long-term debt: $1.9BQ1'23Q2'23, Cash and equivalents: $708MQ2'23, Long-term debt: $2.3BQ3'23, Cash and equivalents: $705MQ3'23, Long-term debt: $2.3BQ3'23Q4'23, Cash and equivalents: $1.0BQ4'23, Long-term debt: $2.3BQ1'24, Cash and equivalents: $947MQ1'24, Long-term debt: $2.0BQ1'24Q2'24, Cash and equivalents: $815MQ2'24, Long-term debt: $2.0BQ3'24, Cash and equivalents: $989MQ3'24, Long-term debt: $2.0BQ3'24Q4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $2.0BQ1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $2.0BQ1'25Q2'25, Cash and equivalents: $1.2BQ2'25, Long-term debt: $1.9BQ3'25, Cash and equivalents: $1.2BQ3'25, Long-term debt: $1.9BQ3'25Q4'25, Cash and equivalents: $1.5BQ4'25, Long-term debt: $1.4BQ1'26, Cash and equivalents: $808MQ1'26, Long-term debt: $1.4BQ1'26Q2'26, Cash and equivalents: $1.3BQ2'26, Long-term debt: $2.4BQ3'26, Cash and equivalents: $708MQ3'26, Long-term debt: $2.4BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.

Xylem Inc income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 27, 2026Q2 FY2026ended Jun 30, 2026filed Jul 28, 2026Q1 FY2026ended Mar 31, 2026filed Apr 28, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025Q1 FY2025ended Mar 31, 2025filed Apr 29, 2025Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue2,2012,3362,1252,3972,2682,3012,0692,256−3.0%
Cost of revenue1,2941,3731,3221,4651,3851,4091,3011,399−6.6%
Gross profit907963803932883892768857+2.7%
Research and development5659566052585658+7.7%
Selling, general and administrative458503472486474503460507−3.4%
Operating income385390244353334305231267+15.3%
Other income (expense)6(3)0563450.0%
Pretax income365364244368297299217375+22.9%
Income tax77103553571755049+8.5%
Net income291263193335227226169326+28.2%
Diluted EPS ($)1.251.110.79—0.930.930.69—+34.4%
Diluted shares (millions)233237243—244244244——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.

Xylem Inc balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 27, 2026Q2 FY2026ended Jun 30, 2026filed Jul 28, 2026Q1 FY2026ended Mar 31, 2026filed Apr 28, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025Q1 FY2025ended Mar 31, 2025filed Apr 29, 2025Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents7081,2768081,4791,1911,1701,0591,121−40.6%
Short-term investments—————————
Total current assets3,9524,3944,0304,6414,4414,3694,0844,098−11.0%
Total assets17,32617,34216,95417,63417,29517,19116,55916,493+0.2%
Total current liabilities2,8422,7242,7552,8562,2692,3012,1662,336+25.3%
Long-term debt2,3652,3951,4071,4081,9131,9281,9741,978+23.6%
Total liabilities6,8156,6765,7255,8855,8505,8825,5055,611+16.5%
Stockholders’ equity10,26910,42110,97211,48011,20711,07410,81610,642−8.4%
Shares outstanding (millions)229233238243243243243243—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.

Xylem Inc cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 27, 2026Q2 FY2026ended Jun 30, 2026filed Jul 28, 2026Q1 FY2026ended Mar 31, 2026filed Apr 28, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025Q1 FY2025ended Mar 31, 2025filed Apr 29, 2025Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow33129010854336030533575−8.1%
Capital expenditures89899083799871100+12.7%
Free cash flow (CFO − capex)24220118460281207(38)475−13.9%
Depreciation and amortization———143———142—
Share repurchases337680563110131+33600.0%
Dividends paid1001011069897989887+3.1%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 25, 2026.

Income statement

Xylem Inc income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Mar 3, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 26, 2021FY2019ended Dec 31, 2019filed Feb 28, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 23, 2018FY2016ended Dec 31, 2016filed Feb 23, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 25, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Nov 21, 2011FY2009ended Dec 31, 2009filed Nov 21, 2011
Revenue9,0358,5627,3645,5225,1954,8765,2495,2074,7073,7713,6533,9163,8373,7913,8033,2022,849
Cost of revenue5,5605,3504,6473,4383,2203,0463,2033,1812,8602,3092,2492,4032,3382,2892,3421,9881,812
Gross profit3,4753,2122,7172,0841,9751,8302,0462,0261,8471,4621,4041,5131,4991,5021,4611,2141,037
Research and development226230232206204187191189181110951041041061007463
Selling, general and administrative1,9231,9111,7571,2271,1791,1431,1581,1611,089914854920990914877737667
Operating income1,2231,009652622585367486654552408449463363443395388276
Other income (expense)18163370(5)(4)136201(10)0501
Pretax income1,1811,087635440511285416585466340403421298388383388277
Income tax23119726858431153613680638470911045914
Net income957890609355427254401549331260340337228297279329263
Diluted EPS ($)3.923.652.791.962.351.402.213.031.831.451.871.831.221.591.501.781.42
Diluted shares (millions)244244218181182181181181181180182184186186185185185

Balance sheet

Xylem Inc balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Mar 3, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 26, 2021FY2019ended Dec 31, 2019filed Feb 28, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 23, 2018FY2016ended Dec 31, 2016filed Feb 23, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 25, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Nov 21, 2011FY2009ended Dec 31, 2009filed Nov 21, 2011
Cash and equivalents1,4791,1211,0199441,3491,875724296414308680663533504318131131
Short-term investments——————0——————————
Total current assets4,6414,0983,8843,0123,1603,5232,4502,0942,0711,8392,0052,0642,0091,8741,6491,336—
Total assets17,63416,49316,1127,9528,2768,7507,7107,2226,8606,4744,6574,8334,8574,6794,4003,735—
Total current liabilities2,8562,3362,2051,5901,3911,9561,5011,3891,1001,238823903853781817649—
Long-term debt1,4081,9782,2681,8802,4402,4842,0402,0512,2002,1081,1961,1951,1991,1991,2014—
Total liabilities5,8855,6115,9364,4495,0505,7744,7434,4404,3414,2672,5732,7062,6552,6052,5691,016—
Stockholders’ equity11,48010,64210,1663,4943,2182,9682,9572,7682,5032,1902,0842,1272,2412,0741,8312,7231,691
Shares outstanding (millions)243243242180180180180180180179178182185186185——

Cash flow statement

Xylem Inc cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Mar 3, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 26, 2021FY2019ended Dec 31, 2019filed Feb 28, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 23, 2018FY2016ended Dec 31, 2016filed Feb 23, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 25, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Nov 21, 2011FY2009ended Dec 31, 2009filed Nov 21, 2011
Operating cash flow1,2411,263837596538824839586686497464416324396449395370
Capital expenditures3313212712082081832262371701241171191261121269462
Free cash flow (CFO − capex)910942566388330641613349516373347297198284323301308
Depreciation and amortization5755624362362452512572612341511331421501421379270
Share repurchases1520255268614059254179134731300—
Dividends paid391350299217203188174152130112102948775190—

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$986K
1 purchases by 1 insider; officers and directors $986K
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$1M
2 purchases by 2 insiders; officers and directors $1M
Sold, twelve months
$753K
2 sales by 2 insiders; officers and directors $753K

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 29, 2026Koch D ChristianDirectoropen-market buy11,000$89.60$986K12,247Oct 29, 2026
Oct 21, 2026Emmerich MeredithEVP & President, MCStax withholding837$106.35$89K4,610Oct 21, 2026
Oct 1, 2026McShane Geri-MichelleSVP, CAOaward4,257$0.00—7,862Oct 9, 2026
Oct 1, 2026McShane Geri-MichelleSVP, CAOaward4,225$0.00—7,830Oct 1, 2026
Sep 1, 2026van der Berg Andrea MicheleEVP & Chief Financial Officeraward1,693$0.00—10,691Sep 2, 2026
Sep 1, 2026Johnston Joseph PatrickEVP & President, AWaward645$0.00—2,285Sep 2, 2026
Aug 13, 2026Koch D ChristianDirectoraward1,247$120.27$150K1,247Aug 14, 2026
May 14, 2026Yadav UdayDirectoraward1,711$116.88$200K10,337May 15, 2026
May 14, 2026Tretikov LilaDirectoraward1,711$116.88$200K10,406May 15, 2026
May 14, 2026Peribere Jerome ADirectoraward1,711$116.88$200K5,747May 15, 2026
May 14, 2026Morelli Mark DDirectoraward1,711$116.88$200K8,026May 15, 2026
May 14, 2026Harker Victoria DDirectoraward1,711$116.88$200K18,586May 15, 2026
May 14, 2026Glatch LisaDirectoraward1,711$116.88$200K6,874May 15, 2026
May 14, 2026Friel Robert FDirectoraward2,481$116.88$290K38,706May 15, 2026
May 14, 2026Ellis Earl RayDirectoraward1,711$116.88$200K6,038May 15, 2026
May 7, 2026McShane Geri-MichelleSVP, CAOoption exercise3,147$86.76$273K7,874May 8, 2026
May 7, 2026McShane Geri-MichelleSVP, CAOopen-market sale4,269$117.46$501K3,605May 8, 2026
May 4, 2026Peribere Jerome ADirectoropen-market buyindirect1,210$116.61$141K27,209May 4, 2026
Mar 5, 2026McShane Geri-MichelleSVP, CAOtax withholding64$126.19$8K4,727Mar 6, 2026
Mar 5, 2026Toussaint Claudia SEVP, CP&SOtax withholding305$126.19$38K9,037Mar 6, 2026
Mar 5, 2026Yarkadas HayatiEVP & President, WItax withholding41$126.19$5K33,540Mar 6, 2026
Mar 5, 2026Pine Matthew FrancisPres. & CEO, Directortax withholding1,846$126.19$233K45,105Mar 6, 2026
Mar 5, 2026McGann Michael J.EVP & President, MCStax withholding238$126.19$30K11,987Mar 6, 2026
Mar 5, 2026Grogan William KEVP & Chief Financial Officertax withholding641$126.19$81K39,510Mar 6, 2026
Mar 5, 2026Emmerich MeredithEVP & Pres, AWtax withholding158$126.19$20K5,447Mar 6, 2026

Full insider history for Xylem Inc, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Xylem Inc., CIK 1524472 on EDGAR
Extract generated
November 1, 2026
Withheld
none
Repaired
2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2018, income tax FY2023
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNet
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 1, 2026.

JSON file
/data/financials/XYL.json